Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting. [electronic resource]
Producer: 20040225Description: E19 p. digitalISSN:- 1097-6744
- Abciximab
- Antibodies, Monoclonal -- therapeutic use
- Aspirin -- administration & dosage
- Blood Platelets -- metabolism
- Clopidogrel
- Coronary Disease -- blood
- Drug Therapy, Combination
- Endothelium, Vascular -- metabolism
- Female
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Male
- Middle Aged
- P-Selectin -- metabolism
- Platelet Activation -- drug effects
- Platelet Aggregation -- drug effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Prospective Studies
- Stents
- Ticlopidine -- administration & dosage
- Tirofiban
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.